Vistin Pharma AS (VISTIN):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Vistin Pharma AS (VISTIN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8147
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ノルウェー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Vistin Pharma AS (Vistin), a subsidiary of Vistin Pharma ASA is a healthcare company that produces and supplies active pharmaceutical ingredients and solid dosage forms. The company’s products include opioids, an analgesics and antitussive; metformin, an API for the treatment of diabetes II; and pholcodine, an antitussive. It also provides branded and patented combinations products and plain generic and branded generic metformin tablets. Vistin Pharma offers contract manufacturing for granulate and solid dosage forms and offers customer service, technical services and logistics services. The company provides its products and services to international pharmaceutical companies. It operates through a network of distributors and agents located across Africa, Europe, Asia, and the Americas. The company’s manufacturing facilities are located in Sannidal and Kragero, Norway. Vistin Pharma is headquartered in Oslo, Norway.

Vistin Pharma AS (VISTIN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vistin Pharma AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Vistin Pharma AS, Pharmaceuticals & Healthcare, Deal Details 10
Equity Offering 10
Vistin Pharma Raises USD6.2 Million in Private Placement of Shares 10
Vistin Pharma Raises USD38.8 Million in Private Placement of Shares 12
Vistin Pharma Raises USD20 Million in Rights Offering of Shares 13
Asset Transactions 14
TPI Enterprises Acquires Opioids and CMO Business from Vistin Pharma 14
Acquisition 15
Geveran Trading Divests 5.17% Stake in Vistin Pharma 15
Vistin Pharma AS – Key Competitors 16
Vistin Pharma AS – Key Employees 17
Vistin Pharma AS – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Strategy And Business Planning 19
Jan 30, 2018: Vistin Pharma ASA : Vistin Pharma to postpone the expansion of the metformin production capacity 19
Financial Announcements 20
Aug 30, 2018: Vistin Pharma announces 20 per cent revenue growth in second quarter 2018 20
Apr 26, 2018: Vistin Pharma : Delivers 22% revenue growth in first quarter 2018 21
Feb 27, 2018: Vistin Pharma : Fourth quarter 2017 results 22
Oct 27, 2017: Vistin Pharma: Third quarter 2017 results – strong growth, capacity expansion on track 23
Apr 26, 2017: Vistin Pharma: First quarter 2017 results 24
Feb 28, 2017: Vistin Pharma: Fourth quarter and preliminary 2016 results 25
Other Significant Developments 26
Aug 31, 2017: Vistin Pharma Second quarter 2017 results – continuing strong demand for metformin 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Vistin Pharma AS, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vistin Pharma AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vistin Pharma AS, Deals By Therapy Area, 2012 to YTD 2018 8
Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Vistin Pharma Raises USD6.2 Million in Private Placement of Shares 10
Vistin Pharma Raises USD38.8 Million in Private Placement of Shares 12
Vistin Pharma Raises USD20 Million in Rights Offering of Shares 13
TPI Enterprises Acquires Opioids and CMO Business from Vistin Pharma 14
Geveran Trading Divests 5.17% Stake in Vistin Pharma 15
Vistin Pharma AS, Key Competitors 16
Vistin Pharma AS, Key Employees 17

List of Figures
Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Vistin Pharma AS (VISTIN):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sundaram Finance Limited:企業の戦略・SWOT・財務情報
    Sundaram Finance Limited - Strategy, SWOT and Corporate Finance Report Summary Sundaram Finance Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Meiji Holdings Co, Ltd.:企業の戦略・SWOT・財務情報
    Meiji Holdings Co, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Meiji Holdings Co, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • JSR Corporation (4185):企業の財務・戦略的SWOT分析
    JSR Corporation (4185) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Dick’s Sporting Goods Inc:戦略・SWOT・企業財務分析
    Dick’s Sporting Goods Inc - Strategy, SWOT and Corporate Finance Report Summary Dick’s Sporting Goods Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • SeraCare Life Sciences, Inc.:医療機器:M&Aディール及び事業提携情報
    Summary SeraCare Life Sciences, Inc. (SeraCare) carries out the discovery, development, manufacture and supply of disease-state specimens and tissues for research and development, processed biological materials, immunoassay reagents and quality control products and technologies. Its major products i …
  • Discovery Holdings Limited (DSY):企業の財務・戦略的SWOT分析
    Discovery Holdings Limited (DSY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Stanbic IBTC Holdings Plc:企業の戦略・SWOT・財務情報
    Stanbic IBTC Holdings Plc - Strategy, SWOT and Corporate Finance Report Summary Stanbic IBTC Holdings Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Future Plc (FUTR):企業の財務・戦略的SWOT分析
    Summary Future Plc (Future) is a media company that offers media and digital business solutions various customers. The company offers its services in various areas such as technology, photography, creative and design, games, advertising and film and music. It provides licensing and syndication, expo …
  • OpGen Inc (OPGN):製薬・医療:M&Aディール及び事業提携情報
    Summary OpGen Inc (OpGen) is a molecular diagnostics company that harnesses genomic analysis and bioinformatics to prevent the threat of antibiotic resistance and multi drug resistant organisms (MDROs). The company’s clinical laboratory services include high resolution microbial sequence analysis, s …
  • SPAR International:企業の戦略・SWOT・財務分析
    SPAR International - Strategy, SWOT and Corporate Finance Report Summary SPAR International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Bandwidth Inc (BAND):企業の財務・戦略的SWOT分析
    Bandwidth Inc (BAND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Mears Group PLC (MER):企業の財務・戦略的SWOT分析
    Summary Mears Group PLC (Mears) is a housing and social care provider. The company offers repairs, rapid response and planned maintenance services for a portfolio of social homes. It provides housing services such as new homes, energy services, housing management, home improvement, branches, planned …
  • The Bank Of East Asia, Limited
    The Bank Of East Asia, Limited - Strategy, SWOT and Corporate Finance Report Summary The Bank Of East Asia, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Otsuka Holdings Co Ltd (4578):企業の財務・戦略的SWOT分析
    Otsuka Holdings Co Ltd (4578) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Pro-Dex Inc (PDEX)-医療機器分野:企業M&A・提携分析
    Summary Pro-Dex Inc (Pro-Dex) is a medical device company that manufactures and markets surgical devices. The company’s products comprise motion control, finished medical devices, plastic injection molding, micro air-motors, dental products, and torque wrenches. Its dental products include DLS handp …
  • Canadian Natural Resources Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Canadian Natural Resources Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Canadian Natural Resources Ltd (Canadian Natural) is an independent upstream oil and gas company. The company carries out acquisition, exploration, development, production, marketing a …
  • Matsuda Sangyo Co Ltd (7456):企業の財務・戦略的SWOT分析
    Matsuda Sangyo Co Ltd (7456) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Electromagnetic Geoservices ASA (EMGS):石油・ガス:M&Aディール及び事業提携情報
    Summary Electromagnetic Geoservices ASA (EMGS) is an oil and gas service provider that explores workflow working with seismic, petrophysical and geologic data. The company gathers controlled source electromagnetic data and conduct modeling, integration, interpretation. Its technology finds applicati …
  • Al Arrab Contracting Company:企業の戦略的SWOT分析
    Al Arrab Contracting Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • GlaxoSmithKline Plc:企業のM&A・事業提携・投資動向
    GlaxoSmithKline Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's GlaxoSmithKline Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆